cdmo.directory
← Compare landing

Genevoyager (Wuhan) Co., Ltd. vs Lonza Cell & Gene Technologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/genevoyager-2/lonza

CategoryGenevoyager (Wuhan) Co., Ltd.Lonza Cell & Gene Technologies
Listed sitebothcdmo
SummaryLeading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.
Services
  • Translational Research
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • Cell-Line Development
  • Protein Engineering
  • Analytical Method Development & Validation
  • Process Development
  • Formulation Development
  • Technology Transfer
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Regulatory Affairs
  • Cell Therapy Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Quality Control Testing
  • Microbiology Services
  • Translational Research
  • CMC Analytical Development
  • Stability Testing & Storage
Modalities
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
  • Headquarters, Basel, Basel-Stadt, Switzerland
Certifications
  • China · Identifier: High-tech Enterprise (高新技术企业)
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.